Fig. 2

Development and validation of prognosis lncRNAs signature. Risk value and survival status (a), expression (b), K–M curve (c), ROC curve (d) of the prognostic signature in the training group. Risk value and survival status (e), expression (f), K–M curve (g), and ROC curve (h) of the prognostic signature in the validation group. Risk value and survival status (i), expression (j), K–M curve (k), and ROC curve (l) of the prognostic signature in the entire group. *p  < 0.05, **p  < 0.01, ***p  < 0.001